|
All |
Any complication |
No complication |
p-value |
Operative time (min) |
586 ± 167
(391-1125)
n=34 |
615.1 ± 121
(400-848)
n=14 |
566.4 ± 194.4 (391-1125)
n=20 |
0.17 |
EBL (ml) |
591.8 ± 611.4 (100-2450)
n=33 |
835.7 ± 810.8 (150-2450)
n=14 |
412.1 ± 330.8 (100-1650)
n=19 |
0.47 |
Initial HCT (%) |
38.2 ± 5.5
(25.1-47.2)
n=34 |
36 ± 5.4
(25.1-43.5)
n=14 |
39.7 ± 5.2
(29-47.2)
n=20 |
0.05 |
Maximum glucose (mg/dl) during HIPEC phase |
140 ± 27.9
(72-187)
n=24 |
146.7 ± 23
(98-187)
n=11 |
134.3 ± 31.2
(72-185)
n=13 |
0.35 |
Initial CVP (mmHg) |
10.9 ± 4.3
(2-19)
n=31 |
12.1 ± 4.5
(2-19)
n=14 |
9.9 ± 4
(4-19)
n=17 |
0.09 |
End of case CVP (mmHg) |
9.9 ± 3.3
(5-18)
n=29 |
10 ± 3.6
(6-18)
n=12 |
9.9 ± 3.1
(5-16)
n=17 |
0.89 |
Postoperative pH |
7.39 ± 0.07
(7.25-7.54 )
n=31 |
7.40 ± 0.07
(7.30-7.54)
n=13 |
7.38 ± 0.06
(7.25-7.54)
n=18 |
0.66 |
Intraoperative highest temperature (oC) |
38.1 ± 0.9
(35.9-40.1)
n=27 |
38.2 ± 1
(36.4-40.1)
n=12 |
38 ± 0.9
(35.9-39.7)
n=15 |
0.59 |